α-Glucosidase inhibition of lactone intermediates of the iminosugar deoxynojirimycin

α-Glucosidase inhibition of lactone intermediates of the iminosugar deoxynojirimycin

α-Glycosidase enzymes hydrolyse α-glycosidic linkages and are involved in bodily processes such as the catabolism of glycans, intestinal digestion, and the degradation of glycoproteins. Various types of diseases which are caused by the failure of this enzyme to function prope...

Bibliografiset tiedot
Päätekijät:	Wai Haan, Y, Al-Bajalan, H, Eukun Sage, E, Elangovan, D, Liana Mat Yajit, N, Maisarah Sarizan, N, Zitzmann, N, Kiappes, J, Aishah Hasbullah, S, Hadiani Ismail, N, Mohamed Mackeen, M
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Penerbit UTM Press 2019

Samankaltaisia teoksia

Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells
Tekijä: Perera, N, et al.
Julkaistu: (2022)

Iminosugar 1-Deoxynojirimycin (DNJ) sebagai Antiviral Infeksi Virus Dengue
Tekijä: Muhammad Luthfi Adnan
Julkaistu: (2020-12-01)

Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals
Tekijä: Caputo, A, et al.
Julkaistu: (2016)

Iminosugars inhibit dengue virus production via inhibition of ER alpha-glucosidases – not glycolipid processing enzymes
Tekijä: Sayce, AC, et al.
Julkaistu: (2016)

Targeting ER α-glucosidase I with a single-dose iminosugar treatment protects against lethal influenza and dengue virus infections
Tekijä: Warfield, K, et al.
Julkaistu: (2020)

Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
Tekijä: Andrew C Sayce, et al.
Julkaistu: (2016-03-01)

Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
Tekijä: Warfield, KL, et al.
Julkaistu: (2016)

Iminosugar for treatment of tumors
Tekijä: Dwek, R, et al.
Julkaistu: (2008)

Use of iminosugar derivatives to inhibit ion channel activity
Tekijä: Zitzmann, N, et al.
Julkaistu: (2004)

Iminosugar antivirals: the therapeutic sweet spot
Tekijä: Alonzi, D, et al.
Julkaistu: (2017)

Mechanisms of antiviral activity of iminosugars against dengue virus
Tekijä: Miller, JL, et al.
Julkaistu: (2018)

Iminosugars and methods of treating Arenaviral infections
Tekijä: Ramstedt, U, et al.
Julkaistu: (2010)

Iminosugars and methods of treating viral diseases
Tekijä: Ramstedt, U, et al.
Julkaistu: (2011)

Iminosugars and methods of treating Filoviral diseases
Tekijä: Ramstedt, U, et al.
Julkaistu: (2011)

Synthesis and Evaluation of Phenyltriazole-Deoxynojirimycin Hybrids as Potent α-Glucosidase Inhibitors
Tekijä: Lin Wang, et al.
Julkaistu: (2024-10-01)

Iminosugars: promising therapeutics for influenza infection
Tekijä: Tyrrell, B, et al.
Julkaistu: (2016)

Structural studies of Endoplasmic Reticulum Glucosidase II
Tekijä: Caputo, A, et al.
Julkaistu: (2015)

Iminosugars and methods of treating Bunyaviral and Togaviral diseases
Tekijä: Ramstedt, U, et al.
Julkaistu: (2010)

Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors
Tekijä: Kato, A, et al.
Julkaistu: (2015)

Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors.
Tekijä: Kato, A, et al.
Julkaistu: (2015)

Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors.
Tekijä: Rawlings, A, et al.
Julkaistu: (2009)

N-alkyl deoxynojirimycins as antiviral compounds.
Tekijä: Moriarty, R, et al.
Julkaistu: (2002)

Antiviral effects of an iminosugar derivative on flavivirus infections.
Tekijä: Wu, S, et al.
Julkaistu: (2002)

Metabolic engineering of Bacillus amyloliquefaciens for efficient production of α-glucosidase inhibitor1-deoxynojirimycin
Tekijä: Xujie Li, et al.
Julkaistu: (2023-09-01)

SYNTHESIS OF DEOXYNOJIRIMYCIN AND OF NOJIRIMYCIN DELTA-LACTAM
Tekijä: Fleet, G, et al.
Julkaistu: (1990)

No evidence for drug resistance by iminosugar-based HCV assembly inhibitors in tissue culture
Tekijä: Steinmann, E, et al.
Julkaistu: (2010)

Iminosugars counteract the downregulation of the interferon gamma receptor by dengue virus
Tekijä: Miller, J, et al.
Julkaistu: (2019)

Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
Tekijä: Steinmann, E, et al.
Julkaistu: (2007)

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
Tekijä: Durantel, D, et al.
Julkaistu: (2001)

Long alkylchain iminosugars block the HCV p7 ion channel
Tekijä: Pavlovic, D, et al.
Julkaistu: (2005)

Structural insights into the broad-spectrum antiviral target endoplasmic reticulum alpha-glucosidase II
Tekijä: Zitzmann, N, et al.
Julkaistu: (2018)

Improved cellular inhibitors for glycoprotein processing alpha-glucosidases: biological characterisation of alkyl- and arylalkyl-N-substituted deoxynojirimycins
Tekijä: Alonzi, D, et al.
Julkaistu: (2009)

Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.
Tekijä: Durantel, D, et al.
Julkaistu: (2004)

Strain-specific antiviral activity of iminosugars against human influenza A viruses.
Tekijä: Hussain, S, et al.
Julkaistu: (2015)

Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals
Tekijä: Brun, J, et al.
Julkaistu: (2025)

Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response
Tekijä: Sayce, AC, et al.
Julkaistu: (2021)

Iminosugar NB-DNJ delays mortality in lethal model of dengue virus infection in mice
Tekijä: Beatty, P, et al.
Julkaistu: (2009)

N-Butyl-L-Deoxynojirimycin (L-NBDNJ): Synthesis of an allosteric enhancer of α-glucosidase activity for the treatment of Pompe disease
Tekijä: D'Alonzo, D, et al.
Julkaistu: (2017)

Iminosugars With Endoplasmic Reticulum α-Glucosidase Inhibitor Activity Inhibit ZIKV Replication and Reverse Cytopathogenicity in vitro
Tekijä: Gitanjali Bhushan, et al.
Julkaistu: (2020-04-01)

Culture long-term treatment with iminosugars-based HCV assembly inhibitors does not lead to viral breakthrough in tissue culture
Tekijä: Steinmann, E, et al.
Julkaistu: (2011)